KMID : 0387820020090010009
|
|
Clinical Pediatric Hematology-Oncology 2002 Volume.9 No. 1 p.9 ~ p.20
|
|
Epidemiolohy and Clinical Characteristics of Childhood Acute Lymphoblastic Leukemia in Korea
|
|
Lee Kwang-Chul
Kang Im-Joo Kang Shin-Heh Koo Hong-Hoe Kook Hoon Kim Kr-Young Kim Moon-Kyu Kim Soon-Kyum Kim Hack-Ki Kim Hwang-Min Kim Heung-Sik Nam Seung-Kon Moon Hyung-Nam Park Kyung-Duk Park Sae-Myung Park Jae-Sun Park Jong-Young Park Hyun-Jin Seh Won-Suk Seo Jong-Jin Sung Ki-Woong Shin Sang-Man Shin Hee-Young Shim Tae-Sub Ahn Don-Hee Ahn Hyo-Seop Yang Chang-Hyun Yang Eun-Suk Woo Chan-Wook Ryu Kyung-Ha Yoo Eun-Sun Lyu Chuhl-Joo Lee Kun-Soo Lee Soon-Yong Lee Young-Ho Lee Hahng Lim Young-Tak Im Ho-Jun Cho Bin Cho Hyun-Sang Choi Kyu-Chul Choi Doo-Young Choi Sang-Wook Choi Young-Mook Hah Jeong-Ok Hwang Pyoung-Han Hwang Tae-Ju
|
|
Abstract
|
|
|
Purpose:Acute lymphoblastic leukemia (ALL) accounts for approximately 75% of all cases of childhood leukemia. We investigated epidemiology, clinical and laboratory features and treatment outcome of the children with ALL in Korea during recent 5 years.
Methods:One thousand forty nine patients were enrolled between January 1994 and December 1998 from 37 major ospitals in Korea. The data regarding the clinical and laboratory features including age, WBC counts at diagnosis, immunophenotype, morphology, cytogenetics and treatment outcome of patients were analyzed retrospectively by review of patient¡¯s medical records. Kaplan-Meier survival curves were constructed. The differences between groups analyzed by log-rank test.
Results:There were 597 males and 452 females. The distribution between the age 2 and 5 years is most common in 46.1%. The annual incidence rate per 100,000 population varied from 1.6 to 2.2. The 5 year event free survival (EFS) rates according to good prognostic factors were as follows: 67% bet ween 1-9 year of age at diagnosis, 69% in under 10,000/mm3of initial WBC count, 74% in early pre-B cell CALLA ( ) immunophenotype, 65% in L3 morphology, 68% in no CNS invasion. Most of patients were treated by CCG treatment protocol. The 5 year EFS was 63%. Main complications were sepsis (21.8%) and hemorrhage (12.5%). The relapse rate was 15.6%. The common causes of death were sepsis, DIC, pneumonia, relapse.
Conclusion:Our results could provide the most recent and important information about acute lymphoblastic leukemia of children in Korea.
|
|
KEYWORD
|
|
Acute lymphoblastic leukemia, Epidemiolohy, Event free survival, Children
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|